Terms: = Liver cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
29 results:
1. Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.
Xu Y; Sun F; Tian Y; Zeng G; Lei G; Bai Z; Wang Y; Ge X; Wang J; Xiao C; Wang Z; Hu M; Song J; Yang P; Liu R
Int Immunopharmacol; 2024 Mar; 129():111628. PubMed ID: 38320351
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and validation of a novel lysosome-related gene signature for predicting prognosis and immune landscape in hepatocellular carcinoma.
Li H; Li J; Qu X; Dai H; Liu J; Ma M; Wang J; Dong W; Wang W
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17543-17557. PubMed ID: 37903936
[TBL] [Abstract] [Full Text] [Related]
3. Association between oxidative stress, mitochondrial function of peripheral blood mononuclear cells and gastrointestinal cancers.
Liu W; Gao Y; Li H; Wang X; Jin M; Shen Z; Yang D; Zhang X; Wei Z; Chen Z; Li J
J Transl Med; 2023 Feb; 21(1):107. PubMed ID: 36765353
[TBL] [Abstract] [Full Text] [Related]
4. Clinical application study on miR-98-5p as a prognostic biomarker in hepatocellular carcinoma.
Ji PT; Wang XY
Clin Res Hepatol Gastroenterol; 2023 Feb; 47(2):102077. PubMed ID: 36623770
[TBL] [Abstract] [Full Text] [Related]
5. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal cancer.
Hao T; Yu H; Huang D; Liu Q
Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
[TBL] [Abstract] [Full Text] [Related]
6. The inhibition of il-2/il-2R gives rise to CD8
Shi H; Wang W; Yin J; Ouyang Y; Pang L; Feng Y; Qiao L; Guo X; Shi H; Jin R; Chen D
Cell Death Dis; 2020 Jun; 11(6):429. PubMed ID: 32513989
[TBL] [Abstract] [Full Text] [Related]
7. Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients.
Mao JX; Guo WY; Guo M; Liu C; Teng F; Ding GS
Hepatol Int; 2020 May; 14(3):347-361. PubMed ID: 32140981
[TBL] [Abstract] [Full Text] [Related]
8. FOXA1
Liang J; Tian C; Zeng Y; Yang Q; Liu Y; Liu Y; Wu J; Hu Y; Gu F; Zhang K; Wang Y; Zhang Y; Liu L
Biochem Biophys Res Commun; 2019 Jun; 514(1):308-315. PubMed ID: 31036318
[TBL] [Abstract] [Full Text] [Related]
9. Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization.
Lee HL; Jang JW; Lee SW; Yoo SH; Kwon JH; Nam SW; Bae SH; Choi JY; Han NI; Yoon SK
Sci Rep; 2019 Mar; 9(1):3260. PubMed ID: 30824840
[TBL] [Abstract] [Full Text] [Related]
10. In Vitro Killing of Colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation Status.
Turin I; Delfanti S; Ferulli F; Brugnatelli S; Tanzi M; Maestri M; Cobianchi L; Lisini D; Luinetti O; Paulli M; Perotti C; Todisco E; Pedrazzoli P; Montagna D
J Immunother; 2018 May; 41(4):190-200. PubMed ID: 29293164
[TBL] [Abstract] [Full Text] [Related]
11. Genetically engineered recombinant adenovirus expressing interleukin‑2 for hepatocellular carcinoma therapy.
Sun Y; Wu H; Chen G; Huang X; Shan Y; Shi H; Zhang Q; Zheng Y
Mol Med Rep; 2018 Jan; 17(1):300-306. PubMed ID: 29115604
[TBL] [Abstract] [Full Text] [Related]
12. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
[TBL] [Abstract] [Full Text] [Related]
13. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
[TBL] [Abstract] [Full Text] [Related]
14. Dendritic cell vaccination of patients with metastatic colorectal cancer.
Burgdorf SK
Dan Med Bull; 2010 Sep; 57(9):B4171. PubMed ID: 20816019
[TBL] [Abstract] [Full Text] [Related]
15. Interleukin-2 gene expression is a new biological prognostic marker in hepatocellular carcinomas.
Ikeguchi M; Hirooka Y
Onkologie; 2005 May; 28(5):255-9. PubMed ID: 15867481
[TBL] [Abstract] [Full Text] [Related]
16. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract] [Full Text] [Related]
17. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
May M; Helke C; Bock M; Hoschke B
Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
[TBL] [Abstract] [Full Text] [Related]
18. Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma.
Hoshi S; Satoh M; Ohyama C; Hiramatu M; Watanabe R; Hagisawa S; Endo M; Arai Y
Int J Clin Oncol; 2003 Apr; 8(2):113-7. PubMed ID: 12720105
[TBL] [Abstract] [Full Text] [Related]
19. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Sawada M; Yamada T; Tsurumi H; Moriwaki H
Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
[TBL] [Abstract] [Full Text] [Related]
20. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis.
Tang Z; Zhou X; Lin Z; Yang B; Ma Z; Ye S; Wu Z; Fan J; Liu Y; Liu K; Qin L; Tian J; Sun H; He B; Xia J; Qiu S; Zhou J
Chin Med J (Engl); 1999 Oct; 112(10):887-91. PubMed ID: 11717970
[TBL] [Abstract] [Full Text] [Related]
[Next]